MLAB – Mesa Laboratories, Inc.
MLAB — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.71
Margin Of Safety %
14
Put/Call OI Ratio
EPS Next Q Diff
-1.4
EPS Last/This Y
7.71
EPS This/Next Y
-1.96
Price
100.9
Target Price
104.5
Analyst Recom
2.33
Performance Q
10.48
Upside
-91.6%
Beta
0.94
Ticker: MLAB
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-14 | MLAB | 99.15 | N/A | N/A | 0 |
| 2026-04-15 | MLAB | 99.42 | N/A | N/A | 0 |
| 2026-04-16 | MLAB | 98.75 | N/A | N/A | 0 |
| 2026-04-17 | MLAB | 103.13 | N/A | N/A | 0 |
| 2026-04-20 | MLAB | 105.07 | N/A | N/A | 0 |
| 2026-04-21 | MLAB | 101.55 | N/A | N/A | 0 |
| 2026-04-22 | MLAB | 101.22 | N/A | N/A | 0 |
| 2026-04-23 | MLAB | 96.64 | N/A | N/A | 0 |
| 2026-04-24 | MLAB | 97.94 | N/A | N/A | 0 |
| 2026-04-27 | MLAB | 98.1 | N/A | N/A | 0 |
| 2026-04-28 | MLAB | 99.37 | N/A | N/A | 0 |
| 2026-04-29 | MLAB | 95.7 | N/A | N/A | 0 |
| 2026-04-30 | MLAB | 100.08 | N/A | N/A | 0 |
| 2026-05-01 | MLAB | 103.32 | N/A | N/A | 0 |
| 2026-05-04 | MLAB | 102.86 | N/A | N/A | 0 |
| 2026-05-05 | MLAB | 103.61 | N/A | N/A | 0 |
| 2026-05-06 | MLAB | 105.82 | N/A | N/A | 0 |
| 2026-05-07 | MLAB | 105.83 | N/A | N/A | 0 |
| 2026-05-08 | MLAB | 104.77 | N/A | N/A | 0 |
| 2026-05-11 | MLAB | 102.9 | N/A | N/A | 0 |
| 2026-05-12 | MLAB | 103.55 | N/A | N/A | 0 |
| 2026-05-13 | MLAB | 100.43 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-14 | MLAB | 99.07 | 226.0 | - | 7.35 |
| 2026-04-15 | MLAB | 99.59 | 226.0 | - | 7.35 |
| 2026-04-16 | MLAB | 98.75 | 226.0 | - | 7.35 |
| 2026-04-17 | MLAB | 103.28 | 226.0 | - | 7.35 |
| 2026-04-20 | MLAB | 104.87 | 226.0 | - | 7.35 |
| 2026-04-21 | MLAB | 101.75 | 226.0 | - | 7.35 |
| 2026-04-22 | MLAB | 101.06 | 226.0 | - | 7.35 |
| 2026-04-23 | MLAB | 96.61 | 226.0 | - | 7.35 |
| 2026-04-24 | MLAB | 98.15 | 226.0 | - | 7.35 |
| 2026-04-27 | MLAB | 98.34 | 226.0 | - | 7.35 |
| 2026-04-28 | MLAB | 99.69 | 226.0 | - | 7.35 |
| 2026-04-30 | MLAB | 100.03 | 226.0 | - | 7.35 |
| 2026-05-01 | MLAB | 103.16 | 226.0 | - | 7.35 |
| 2026-05-04 | MLAB | 103.08 | 226.0 | - | 7.35 |
| 2026-05-05 | MLAB | 103.78 | 226.0 | - | 7.35 |
| 2026-05-06 | MLAB | 105.97 | 226.0 | - | 7.35 |
| 2026-05-07 | MLAB | 105.83 | 226.0 | - | 7.35 |
| 2026-05-08 | MLAB | 104.80 | 226.0 | - | 7.35 |
| 2026-05-11 | MLAB | 102.70 | 226.0 | - | 7.35 |
| 2026-05-12 | MLAB | 103.67 | 226.0 | - | 7.35 |
| 2026-05-13 | MLAB | 100.90 | 226.0 | - | 7.35 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-14 | MLAB | 3.68 | -7.15 | 4.13 |
| 2026-04-15 | MLAB | 3.68 | -7.15 | 4.13 |
| 2026-04-16 | MLAB | 3.68 | -7.15 | 4.13 |
| 2026-04-17 | MLAB | 3.68 | -7.15 | 4.13 |
| 2026-04-20 | MLAB | 3.68 | -7.29 | 4.13 |
| 2026-04-21 | MLAB | 3.68 | -7.29 | 4.13 |
| 2026-04-22 | MLAB | 3.68 | -7.29 | 4.13 |
| 2026-04-23 | MLAB | 3.68 | -7.29 | 4.13 |
| 2026-04-24 | MLAB | 3.56 | -7.29 | 4.13 |
| 2026-04-27 | MLAB | 3.56 | -7.88 | 3.71 |
| 2026-04-28 | MLAB | 3.56 | -7.88 | 3.71 |
| 2026-04-29 | MLAB | 3.56 | -7.88 | 3.71 |
| 2026-04-30 | MLAB | 3.56 | -7.88 | 3.71 |
| 2026-05-01 | MLAB | 3.56 | -7.88 | 3.71 |
| 2026-05-04 | MLAB | 3.56 | -7.81 | 3.71 |
| 2026-05-05 | MLAB | 3.56 | -7.81 | 3.71 |
| 2026-05-06 | MLAB | 3.56 | -7.81 | 3.71 |
| 2026-05-07 | MLAB | 3.56 | -7.81 | 3.71 |
| 2026-05-08 | MLAB | 3.56 | -7.81 | 3.71 |
| 2026-05-11 | MLAB | 3.56 | -9.82 | 3.71 |
| 2026-05-12 | MLAB | 3.56 | -9.82 | 3.71 |
| 2026-05-13 | MLAB | 3.55 | -9.82 | 3.71 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.46
Avg. EPS Est. Current Quarter
1.39
Avg. EPS Est. Next Quarter
1.06
Insider Transactions
3.55
Institutional Transactions
-9.82
Beta
0.94
Average Sales Estimate Current Quarter
65
Average Sales Estimate Next Quarter
62
Fair Value
114.9
Quality Score
62
Growth Score
77
Sentiment Score
8
Actual DrawDown %
69.7
Max Drawdown 5-Year %
-82.4
Target Price
104.5
P/E
156.12
Forward P/E
11.84
PEG
P/S
2.25
P/B
2.98
P/Free Cash Flow
14.68
EPS
0.65
Average EPS Est. Cur. Y
7.35
EPS Next Y. (Est.)
5.39
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
1.51
Relative Volume
1.13
Return on Equity vs Sector %
-50.1
Return on Equity vs Industry %
-9.8
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.21
EBIT Estimation
◆
MLAB
Technology
$100.79
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
52.9
Range 1M
46.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-13.4%
EPS NY
-6.1%
52W%
63.4%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-10.3% upside
Upside
-10.3%
Quality
62
MoS
14%
Mesa Laboratories, Inc.Sector: Technology
Industry: Scientific & Technical Instruments
Employees: 730
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
MLAB
Latest News
—
Caricamento notizie per MLAB…
stock quote shares MLAB – Mesa Laboratories, Inc. Stock Price stock today
news today MLAB – Mesa Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MLAB – Mesa Laboratories, Inc. yahoo finance google finance
stock history MLAB – Mesa Laboratories, Inc. invest stock market
stock prices MLAB premarket after hours
ticker MLAB fair value insiders trading